A Phase 1 Open-label Study of the Safety, Tolerability, and Pharmacokinetics of d- and l-Amphetamine After Multiple Daily Doses of SHP465 6.25 mg Administered in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder
收藏DataCite Commons2025-12-03 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011135/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of SHP465 in children aged 4 to 5 years with ADHD after multiple daily doses of 6.25 milligram (mg) SHP465
提供机构：
Vivli
创建时间：
2025-02-27
